EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Non–Prostate Cancer‐Related Factors That Influence Serum Prostate‐Specific Antigen: A Narrative Review of 45 Non‐Malignant PSA Modifiers

Carsten Stephan iD, Klaus Jung iD, Siobhan Sutcliffe iD, Xavier Filella iD, Michael B Phillips iD, Howard Wolinsky iD, Kevin Ginsburg iD, David K Keller iD

The Prostate · 09.11.2026

DOI: 10.1002/pros.70272 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Prostate, online erschienen am 09.11.2026. Verfasst von Carsten Stephan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University Hospital Charité, Germany. Die Arbeit nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To consolidate into a single review more than forty non‐cancer‐related factors that have been found to elevate or reduce prostate‐specific antigen (PSA) levels in the peer‐reviewed literature, emphasizing their contribution to false‐positive and false‐negative clinical interpretations. Materials and Methods A narrative literature review was conducted using PubMed, focusing on human studies describing benign physiologic, infectious, inflammatory, iatrogenic, hormonal, pharmacologic, and laboratory‐related factors that influence PSA values. The review emphasizes contemporary studies but incorporates earlier foundational literature where relevant.

Results

Forty‐five non‐cancer‐related factors were identified that influence PSA values through biologic, mechanical, pharmacologic, or analytic mechanisms. Thirty factors were associated with transient or persistent PSA elevation, whereas fifteen were associated with PSA reduction. Some factors varied substantially in the strength, magnitude, and consistency of reported PSA effects across studies. PSA elevations were reported in association with prostatic inflammation or infection, urinary retention, ejaculation, non‐instrumental prostatic physical stimulation, urologic instrumentation, and systemic inflammatory conditions. PSA reductions were observed with medications including 5‐alpha‐reductase inhibitors, nonsteroidal anti‐inflammatory drugs, statins, thiazide diuretics, metformin, and certain lifestyle factors. Inter‐assay and inter‐laboratory variability alone has been reported to result in PSA differences exceeding 20%. Tables summarizing the approximate magnitude and duration of PSA change for each modifier were developed, along with a patient questionnaire intended to support, not replace, clinician judgment.

Conclusion

PSA interpretation must incorporate awareness of more than forty influencers that can alter PSA independent of any malignancy. Accounting for these PSA level‐altering variables can improve PSA test result specificity and enhance confidence in prostate cancer risk assessment. Use of a structured patient questionnaire, a thorough consideration of benign factors that can alter PSA, repeat testing when transient factors are present, and consistent blood assay methodology can reduce unnecessary imaging, unneeded biopsies, and missed malignancies.

Schlagwörter

Stichwörter der Autor:innen

diagnostic errorsfalse‐negative reactionsfalse‐positive reactionssensitivity and specificityurology

Autor:innen und Institutionen

  • Department of Urology, University Hospital Charité, Germany.
  • Professor of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Hospital Clínic de Barcelona, Catalonia, Spain.
  • Department of Internal Medicine, Mayo Clinic, Jacksonville, Florida, USA.
  • Editor, ActiveSurveillor.com, Substack, Chicago, Illinois, USA.
  • Director of Research, Dept of Urology, Karmanos Cancer Institute/Wayne Health, Detroit, Michigan, USA.

ORCID-Profile: Carsten Stephan, Klaus Jung, Siobhan Sutcliffe, Xavier Filella, Michael B Phillips, Howard Wolinsky, Kevin Ginsburg, David K Keller

Zitieren

APA

Stephan, C., Jung, K., Sutcliffe, S., Filella, X., Phillips, M. B., Wolinsky, H., Ginsburg, K., & Keller, D. K. (2026). Non–Prostate Cancer‐Related Factors That Influence Serum Prostate‐Specific Antigen: A Narrative Review of 45 Non‐Malignant PSA Modifiers. The Prostate. https://doi.org/10.1002/pros.70272

Vancouver

Stephan C, Jung K, Sutcliffe S, Filella X, Phillips MB, Wolinsky H, et al. Non–Prostate Cancer‐Related Factors That Influence Serum Prostate‐Specific Antigen: A Narrative Review of 45 Non‐Malignant PSA Modifiers. The Prostate. 2026. doi:10.1002/pros.70272

BibTeX
@article{Stephan2026,
  author = {Stephan, Carsten and Jung, Klaus and Sutcliffe, Siobhan and Filella, Xavier and Phillips, Michael B and Wolinsky, Howard and Ginsburg, Kevin and Keller, David K},
  title = {Non–Prostate Cancer‐Related Factors That Influence Serum Prostate‐Specific Antigen: A Narrative Review of 45 Non‐Malignant PSA Modifiers},
  journal = {The Prostate},
  year = {2026},
  doi = {10.1002/pros.70272}
}
Kostenlos starten →